Skip to content
RecallWatchMedical Device Safety
Root cause

Unknown/Undetermined by firm

An FDA-recorded root-cause determination. The FDA lists 23 recalls with this root cause since 2025, 1 of them Class I (most serious). Most recent report: May 13, 2026.

Class I: 1Class II: 22
Class IIOngoingZ-0039-2026

CORNEAT VISION, LTD. recalls CorNeat EverPatch

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

  • Polymer Eyelid Spacer/Graft Prosthesis
  • Unknown/Undetermined by firm
CORNEAT VISION, LTD.Oct 15, 2025
Class IIOngoingZ-0040-2026

CORNEAT VISION, LTD. recalls EverPatch+

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

  • Polymer Eyelid Spacer/Graft Prosthesis
  • Unknown/Undetermined by firm
CORNEAT VISION, LTD.Oct 15, 2025
Class IIOngoingZ-0036-2026

W L Gore & Associates, Inc. recalls GORE ACUSEAL Vascular Graft

Reports of vascular graft delamination, which may lead to reduced access flow; cannulation difficulties; bleeding or bruising;…

  • Of 6mm And Greater Diameter Vascular Graft Prosthesis
  • Unknown/Undetermined by firm
W L Gore & Associates,…AZOct 8, 2025
Class IIOngoingZ-2537-2025

CORNEAT VISION, LTD. recalls CorNeat EverPatch

Retroactive; Due to complaints, labeling correction for permanent tissue-integrating surgical matrices to include prevention and management of would dehiscence.

  • Polymer Eyelid Spacer/Graft Prosthesis
  • Unknown/Undetermined by firm
CORNEAT VISION, LTD.Sep 17, 2025
Class IIOngoingZ-2077-2025

Geneoscopy, Inc. recalls ColoSense Test Kit

Multiple plate failures documented as a result of the Low Positive Template Control being too high and out of range using the affected lot of ColoSense Test Kit.

  • Rna Markers And Hemoglobin Detection Colorectal Neoplasia System
  • Unknown/Undetermined by firm
Geneoscopy, Inc.MOJul 9, 2025

Source: U.S. FDA openFDA device enforcement + RES recall records. Informational only — verify against the FDA before acting.